HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
Actelion Pharmaceuticals U.S. Deploys Model N Medicaid Claims Processing to Better Manage Governmental Compliance.
-
PR Newswire; Aug 1, 2005; 700+ Words
...Model N, Inc., the pioneer...announced that Actelion Pharmaceuticals U.S., Inc. , a biopharmaceutical...With Model N, Actelion Pharmaceuticals...applications provides us with a revenue...companies like Actelion Pharmaceuticals U.S. in many...mind for growing ...
-
-
Actelion Pharmaceuticals US Selects I-many/Medicaid.
-
Business Wire; Jun 27, 2002; 700+ Words
...Compliance I-many, Inc. (NASDAQ: IMNY...announced today that Actelion Pharmaceuticals US has selected and successfully...many/Medicaid allows Actelion to market their first...Actelion Pharmaceuticals US, Inc., is owned by Actelion...
-
-
Actelion Pharmaceuticals U.S., Inc. Selects Model N Medicaid Claims Processing To Better Manage Governmental Compliance; Biopharmaceutical Innovator Moves to Next Generation Model N Solution as Strategic Platform to Support Company Growth.
-
PR Newswire; Mar 2, 2005; 700+ Words
...With Model N, Actelion will ensure...reimbursement, Actelion Pharmaceuticals...will provide us a with a revenue...government sector." Actelion Pharmaceuticals U.S., Inc., whose parent...successful, growing pharmaceutical companies such...
-
-
DDMAC letter alleges misleading claims made to hospital staff. (Washington Insider).(U.S. Food and Drug Administration, Division of Drug Marketing, Advertising and Communications, oral representations by territory manager of Actelion Pharmaceuticals US Inc.)(Brief Article)
-
Medical Marketing & Media; Jan 1, 2003; 700+ Words
A territory manager from Actelion Pharmaceuticals made false and/or misleading oral representations to a hospital staff member about the use of Tracleer (bosentan) in congestive...
-
-
Biotech's Helix Award Honors Top Performers Onyx Pharmaceuticals and Actelion.
-
PR Newswire; Feb 25, 2004; 700+ Words
...Pharmaceuticals Inc. and Actelion Ltd. have won...category, Onyx Pharmaceuticals , focused its resources...Phase III trial." Actelion Ltd. , the international...Switzerland. Actelion markets two products...significant year for us as we achieved...biotechnology, ...
-
-
Actelion Chooses StayinFront for CRM Solution.
-
Business Wire; Jul 12, 2001; 700+ Words
...Healthcare, Pharmaceutical & High...StayinFront, Inc., a global...announced that Actelion Pharmaceuticals U.S. Inc., has selected...management solution. Actelion, a biopharmaceutical...solution to enable us to effectively...
-
-
Actelion Receives Frost & Sullivan 2007 North American Pulmonary Arterial Hypertension Market Leadership Award.(Industry overview)
-
Business Wire; Sep 20, 2007; 700+ Words
...Leadership of the Year Award to Actelion Pharmaceuticals US, Inc. According to Frost & Sullivan's research, Actelion is the key leader in the U.S...President of Actelion Pharmaceuticals US. "This award recognizes our...
-
-
Actelion Launches Increased Strength Formulation of Ventavis (Iloprost) for Pulmonary Arterial Hypertension in the United States.
-
PR Newswire; Sep 1, 2009; 700+ Words
...FRANCISCO, Calif., Sept. 1 /PRNewswire/ -- Actelion Pharmaceuticals US, Inc., today announced the first commercial sales...Senior Vice President, U.S. Medical Group at Actelion Pharmaceuticals US. "Ventavis is the inhaled prostacyclin with...
-
-
Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information.
-
PR Newswire; Dec 18, 2007; 700+ Words
...Dec. 18 /PRNewswire/ -- Actelion Pharmaceuticals US, Inc. today announced results of...Sure Steps program, part of Actelion's PAH Pathways(TM) service...available to all PAH patients on Actelion's PAH products, Tracleer...
-
-
ACTELION, GENENTECH WIN FDA APPROVAL FOR TRACLEER.(Brief Article)
-
BIOWORLD Today; Nov 26, 2001; ; 700+ Words
Actelion Ltd. celebrated...significant day for us," said Simon Buckingham...Francisco- based Actelion Pharmaceuticals U.S. "This is...based Genentech Inc. now has the option...partnership with Actelion lies in the much...
-
-
Actelion Releases Increased Strength Formulation of Ventavis (Iloprost) for Pulmonary Arterial Hypertension in the U.S.
-
Wireless News; Sep 5, 2009; 432 Words
...in the U.S. Type: News Actelion Pharmaceuticals US announced commercial sales...U.S. Medical Group at Actelion Pharmaceuticals US. "Ventavis is the inhaled...Copyright 2009 Close-Up Media, Inc. All Rights Reserved.
-
-
etrials lands second post-approval trial with Actelion.
-
PR Newswire; Apr 22, 2003; 700+ Words
...etrials Worldwide, Inc., a leading...announced today that Actelion, a Swiss-based global pharmaceutical company, has...the past year, Actelion has been using...Project Sponsor for Actelion's first post...initial work with us, has signed to...etrials Worldwide, Inc. etrials ...
-
-
etrials Lands Second Post-Approval Trial With Actelion; Post-Marketing Project to Use Web-Based ASFlash to Collect Trial Results and Educate.
-
PR Newswire; Apr 22, 2003; 700+ Words
...etrials Worldwide, Inc., a leading...announced today that Actelion, a Swiss-based global pharmaceutical company, has...the past year, Actelion has been using...Project Sponsor for Actelion's first post...initial work with us, has signed to...etrials Worldwide, Inc. etrials ...
-
-
Actelion and Genentech Sign Licensing Agreement For Tracleer 'Bosentan' In The U.S.
-
Business Wire; Dec 13, 2000; 700+ Words
...to co-promote Actelion's drug tezosentan...Clozel, CEO of Actelion. "We are excited...cardiovascular products allow us to broaden the spectrum...and HIV/AIDS. Actelion Ltd., is a biopharmaceutical...Genentech, Inc. is a leading biotechnology...and markets human pharmaceutical for ...
-
-
MERCK, ACTELION ENTER POTENTIAL$272M DEAL ON RENIN INHIBITION.(renin inhibitors for cardio-renal diseases, development agreement)
-
BIOWORLD Today; Dec 5, 2003; ; 700+ Words
...royalties for Actelion if a product is...driver for Merck and Actelion is unclear - especially...based Locus Pharmaceuticals Inc.'s computational...might be to Merck/Actelion's plans is...Day. They told us they are about...
-
-
Feinstein Kean Healthcare Expands Pharmaceutical and Consumer Health Practice Leadership; Parrish, Loeb and Baer Enhance Expertise and Breadth of Services at Leading Communications Consulting Firm.
-
PR Newswire; Nov 12, 2003; 700+ Words
...both large pharmaceutical and biotech...team and gives us geographic...biotech and pharmaceutical industries...products, pharmaceuticals, nutrition...pharmacy, Actelion Pharmaceuticals and The Scleroderma...joins the FKH Pharmaceutical Practice with...Pharmaceuticals, ...
-
-
Phase III Tracleer -- Bosentan -- Study in Chronic Heart Failure Does Not Meet Primary Efficacy Objective.
-
Business Wire; Feb 7, 2002; 700+ Words
...currently marketed by Actelion Pharmaceuticals US. The drug is also available...Australia. Genentech, Inc. Genentech, Inc...under the symbol DNA. Actelion Ltd Actelion Ltd is a...and has a substantial US operation based in South...
-
-
New Studies in Patients With Sickle Cell Disease Who Develop Pulmonary Hypertension-Recruiting Now for Clinical Trials.
-
PR Newswire; Apr 10, 2006; 700+ Words
...physicians can contact Actelion Pharmaceuticals, Inc. (Please call Christine...Martinique About Tracleer and Actelion Ltd Actelion Ltd, a...its subsidiaries in the US, the EU, Japan, Canada...Pharmaceuticals, U.S., Inc., +1-650- 624...
-
-
Panacos Appoints Dr. Tom Lategan, Vice President of Regulatory Affairs.
-
Business Wire; Feb 14, 2007; 700+ Words
...WATERTOWN, Mass. -- Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology...President, Regulatory Affairs for Actelion Pharmaceuticals US Inc. In this role, he was responsible...the regulatory strategy for Actelion's development products and...
-
-
Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension.
-
PR Newswire; Oct 23, 2007; 700+ Words
...Progression - CHICAGO, Oct. 23 /PRNewswire/ -- Actelion Pharmaceuticals US, Inc. today announced positive results from two...Hopkinson, vice president of U.S. medical at Actelion. "Actelion is committed to conducting studies with Tracleer...
|
|